Australia markets closed

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
178.14-1.38 (-0.77%)
At close: 04:00PM EDT
177.57 -0.57 (-0.32%)
Pre-market: 07:24AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
94,880,000
93,775,000
82,584,000
82,059,000
81,581,000
Cost of revenue
30,390,000
29,855,000
28,427,000
27,556,000
27,091,000
Gross profit
64,490,000
63,920,000
54,157,000
54,503,000
54,490,000
Operating expenses
Research development
14,998,000
14,714,000
12,159,000
11,355,000
10,775,000
Selling general and administrative
25,165,000
24,659,000
22,084,000
22,178,000
22,540,000
Total operating expenses
40,163,000
39,373,000
34,243,000
33,533,000
33,315,000
Operating income or loss
24,327,000
24,547,000
19,914,000
20,970,000
21,175,000
Interest expense
130,000
183,000
201,000
318,000
1,005,000
Total other income/expenses net
-3,068,000
-1,641,000
-3,327,000
-3,681,000
-2,782,000
Income before tax
21,209,000
22,776,000
16,497,000
17,328,000
17,999,000
Income tax expense
1,379,000
1,898,000
1,783,000
2,209,000
2,702,000
Income from continuing operations
19,830,000
20,878,000
14,714,000
15,119,000
15,297,000
Net income
19,830,000
20,878,000
14,714,000
15,119,000
15,297,000
Net income available to common shareholders
19,830,000
20,878,000
14,714,000
15,119,000
15,297,000
Basic EPS
-
7.93
5.59
5.74
5.75
Diluted EPS
-
7.81
5.51
5.63
5.61
Basic average shares
-
2,628,965
2,632,512
2,632,507
2,662,324
Diluted average shares
-
2,674,000
2,670,700
2,684,300
2,728,700
EBITDA
-
30,349,000
23,929,000
24,655,000
25,933,000